On Monday shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) closed at $14.20. Sorrento Therapeutics (NASDAQ:SRNE)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainright in a research report issued on Friday. They currently have a $20.00 target priceRead More

On Friday shares of Southwestern Energy Co. (NYSE:SWN) closed at $27.74. Company’s sales growth for last 5 years was 13.50% and EPS growth for next 5 years is recorded as -7.70%. Oppenheimer restated their market perform rating on shares ofRead More

On Friday shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) closed at $13.01. On May 15, Sorrento Therapeutics, Inc. (NASDAQ:SRNE), announced that NantPharma, founded by Dr. Patrick Soon-Shiong and a member of the NantWorks ecosystem of companies, agreed to acquire the rightsRead More

On Wednesday shares of Magal Security Systems Ltd. (NASDAQ:MAGS) closed at $5.00. Company’s sales growth for last 5 years was 7.30%. Magal Security Systems Ltd. (NASDAQ:MAGS) rose Wednesday after the security and protection services company said it has received twoRead More

On Thursday shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) closed at $11.28. Sorrento Therapeutics (NASDAQ:SRNE), said its candidate is coming through in an ongoing Phase III trial. And while the biotech declined to get into specific details, the whiff of successRead More

On Wednesday shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) closed at $10.97. On May 04, Sorrento Therapeutics, Inc. (NASDAQ:SRNE) announce positive results from recently analyzed pharmacokinetic (PK) data from its TRIBECA (TRIal establishing BioEquivalence between Cynviloq™ and Albumin-bound paclitaxel) registrational trial.Read More

On Tuesday shares of CymaBay Therapeutics Inc. (NASDAQ:CBAY) closed at $4.50. On April 23, US-based biopharmaceutical firm CymaBay Therapeutics Inc. (NASDAQ:CBAY) has received orphan drug designation from the US Food and Drug Administration (FDA) for MBX-8025 to treat patients withRead More

On Thursday shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) closed at $10.67. Sorrento Therapeutics, Inc. (NASDAQ:SRNE), announced that Dr. Henry Ji, President and Chief Executive Officer, presented a corporate overview at the Jefferies 2015 Immuno-Oncology Summit on Wednesday, Apr. 15 fromRead More

On Wednesday shares of Philip Morris International, Inc. (NYSE:PM) closed at $78.13. Company’s sales growth for last 5 years was 3.50% and EPS growth for next 5 years is recorded as 5.40%. Philip Morris International Inc. (NYSE:PM) reported that itsRead More

On Friday shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) closed at $11.79. On 30 March, Sorrento Therapeutics, Inc. (NASDAQ:SRNE) announced the appointment of George K. Ng to the position of Executive Vice President & Chief Legal Officer. Weibo Corporation (NASDAQ:WB) inRead More